US OptionsDetailed Quotes
PBYI250117C2500
- 0.45
- 0.000.00%
15min DelayClose Jan 17 16:00 ET
0.00High0.00Low
0.00Open0.45Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover0.00%IV-2.32%PremiumJan 17, 2025Expiry Date0.52Intrinsic Value100Multiplier-5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma6.71Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Puma Biotechnology Stock Discussion
Sign in to post a comment
3
1
$Puma Biotechnology (PBYI.US)$
Puma Biotechnology Announces Initiation of ALISCA™-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
Puma Biotechnology Announces Initiation of ALISCA™-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
1
$Puma Biotechnology (PBYI.US)$
it was always a diamond studded cougar 😉
and sometimes you have to embrace the fear and ride with it 😆
$Puma Biotechnology (PBYI.US)$
it was always a diamond studded cougar 😉
and sometimes you have to embrace the fear and ride with it 😆
$Puma Biotechnology (PBYI.US)$
2
2
2
$Puma Biotechnology (PBYI.US)$ discount over at $Emergent BioSolutions (EBS.US)$ 👈the maker of narcan, saves lives and took in a lot of government funds this last quarter with earnings coming up.
No comment yet
EmotionOutofEquation : analysts fooled me last year with target $14 volatility luckily didn’t bet big size that was 2/3 year projection may be good luck anyway fundamentally buy signal here